学会発表
2017年12月26日 15時19分 [総研 早川 26419]2ccPA attenuates the fibrotic phenotype of dermal fibroblasts from patientswith systemic sclerosis and bleomycin-induced skin fibrosis.
第45回日本免疫学会・学術集会、沖縄県宜野湾市、2016/12
● Tomoaki Higuchi, Yasushi Kawaguchi, Kae Takagi, Akiko Tochimoto,Yuki Ichimura, Yasuhiro Katsumata, Hisae Ichida, Hidenaga Kawasumi, Hirokazu Nishina, Mari Tochihara, Akira Nishino, Shinya Hirahara, Rina Moriyama, Hisashi Yamanaka.
Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis.
ACR 2016, Washington DC. 2016/11